Exchange Traded Funds (ETFs) are a relatively new financial product that has experienced significant growth in the last few years. Leveraged, inverse, and inverse leveraged ETFs—new ETF structures that have become available over the last several years—have recently become the target of regulatory investigations and litigation. This article provides an introduction to ETFs in the context of recent regulatory problems and litigation.
Examining physician practice groups’ options to manage rising administrative and operational complexities
Charles River Associates (CRA) was commissioned by McKesson to analyze the economic role of McKesson’s Management Services Organizations (MSOs) within the...